Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122470202 | 12247020 | 2 | F | 20160920 | 20160407 | 20160926 | EXP | PHHY2016PL042742 | NOVARTIS | 49.00 | YR | F | Y | 0.00000 | 20160926 | CN | COUNTRY NOT SPECIFIED | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122470202 | 12247020 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | U | 22068 | 400 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122470202 | 12247020 | 1 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122470202 | 12247020 | Abdominal pain upper | |
| 122470202 | 12247020 | Alopecia | |
| 122470202 | 12247020 | Amnesia | |
| 122470202 | 12247020 | Anxiety | |
| 122470202 | 12247020 | Asthenia | |
| 122470202 | 12247020 | Attention deficit/hyperactivity disorder | |
| 122470202 | 12247020 | Bone pain | |
| 122470202 | 12247020 | Constipation | |
| 122470202 | 12247020 | Contusion | |
| 122470202 | 12247020 | Depressed mood | |
| 122470202 | 12247020 | Dry skin | |
| 122470202 | 12247020 | Dysgeusia | |
| 122470202 | 12247020 | Dyspnoea | |
| 122470202 | 12247020 | Eczema | |
| 122470202 | 12247020 | Eye colour change | |
| 122470202 | 12247020 | Fatigue | |
| 122470202 | 12247020 | Heart rate increased | |
| 122470202 | 12247020 | Hepatic pain | |
| 122470202 | 12247020 | Hyperhidrosis | |
| 122470202 | 12247020 | Inappropriate schedule of drug administration | |
| 122470202 | 12247020 | Insomnia | |
| 122470202 | 12247020 | Mood swings | |
| 122470202 | 12247020 | Nausea | |
| 122470202 | 12247020 | Onychoclasis | |
| 122470202 | 12247020 | Oropharyngeal pain | |
| 122470202 | 12247020 | Palpitations | |
| 122470202 | 12247020 | Peripheral swelling | |
| 122470202 | 12247020 | Skin lesion | |
| 122470202 | 12247020 | Stress | |
| 122470202 | 12247020 | Swelling face | |
| 122470202 | 12247020 | Tearfulness | |
| 122470202 | 12247020 | Tinnitus | |
| 122470202 | 12247020 | Tremor | |
| 122470202 | 12247020 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122470202 | 12247020 | 1 | 201312 | 0 |